Clinical trial
The Efficacy of Pregabalin as a Monotherapy Versus Combined Pregabalin and Milnacipran in the Management of Fibromyalgia.
NCT03905486 is registered in ClinicalTrials.gov with Yousra Hisham Abdel Fattah as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Efficacy of Pregabalin as a Monotherapy Versus Combined Pregabalin and Milnacipran in the Management of Fibromyalgia.
- Lead sponsor
- Yousra Hisham Abdel Fattah
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 1, 2019
- Completion date
- December 31, 2019
- Enrollment
- 58 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
fibromyalgia, primary